Shona Haston

Dr. Shona Haston

Newcastle University, Newcastle upon Tyne, UK
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2023 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Open access
SHShona Haston
Shona Haston
DLDavid Langton
David Langton
DTDavid Townshend
David Townshend
RBRohan Bhalekar
Rohan Bhalekar
TJThomas Joyce
Thomas Joyce
This study aimed to characterise the damage mechanisms present on the metal components used in various contemporary total ankle replacements. Twenty-seven explanted total ankle replacements comprising 8 different designs (3 fixed bearing and 5 mobile bearing) were analysed using various explant analysis techniques. Pitting and scratching were the most commonly observed wear features. Microscopic analysis revealed metallic pitting on 52% of tibial components and 95% of talar components. Pitting was identified on more cobalt-chromium than titanium alloy tibial components (63% versus 0%). Non-contact profilometry confirmed the presence of pitting, with significant (p < 0.05) differences in the measured average surface roughness values of pitted and unpitted areas for tibial and talar components. There was macroscopically visible sliding plane scratching, indicating the presence of hard third body particles, on 78% of talar components. Changes to the non-articulating surfaces coatings in terms of coating loss and/or changes in reflectivity was identified visually on 80% of metal components. Scanning electron microscopy with energy dispersive X-ray spectroscopy identified metallic embedded debris in 19% of polyethylene inserts. This explant study demonstrates the release of metal debris from both the metallic tibial and talar component articulating surfaces and non-articulating surface coatings of various contemporary total ankle replacements. Metal particulate debris release from total ankle replacements may be more common than previously recognised. Metal debris should be considered in further study into the aetiology of failed total ankle arthroplasty.

SHShona Haston
Shona Haston
SGSean Gill
Sean Gill
KTKatie Twentyman
Katie Twentyman
EGElizabeth Green
Elizabeth Green
OAOpeyemi Agbeleye
Opeyemi Agbeleye
AMAndrew Mkwashi
Andrew Mkwashi
Neurotechnology is a rapidly emerging field with vast potential within healthcare, but also has inherent concerns. There is, therefore, a need to ensure the responsible and ethical development and regulation of these technologies. This horizon scan aimed to provide an overview of neurotechnologies in development and those approved by the FDA as of June 2024 for a range of conditions relating to mental health, healthy ageing, and physical disability. Searches of clinical trials, conferences, journals, and news were performed in March 2024. Relevant technologies were identified through a process of screening, data extraction and synthesis. A total of 81 unique neurotechnologies were identified, with 23 relating to mental health, 31 to healthy ageing, and 42 to physical disability. A total of 79% percent did not yet have FDA approval and 77.4% were at earlier stages of development (pilot/feasibility studies), with 22.6% at pivotal or post-market stages. Digital elements were common features of the technologies, including software, apps, and connectivity to other devices; however, there were only three technologies with an identifiable AI component. A complex regulatory landscape and unique ethical and safety concerns associated with neurotechnology could pose challenges to innovators, though the emerging nature of the field also provides an opportunity to pre-emptively address potential issues.

17 October 2024 in Musculoskeletal Care
Verified
Journal Article
Open access
LTLouise Tanner
Louise Tanner
MSMadeleine Still
Madeleine Still
SGSoheila Ghasri
Soheila Ghasri
ASAdetutu Sadiq
Adetutu Sadiq
BHBethan Harris
Bethan Harris
FPFiona Pearson
Fiona Pearson
Introduction: Musculoskeletal (MSK) conditions are the largest contributor to disability worldwide. The aim of this project was to undertake a horizon scan and generate an evidence gap map (EGM) to highlight technological innovations in development for preventing and managing MSK conditions at early stages of the clinical treatment pathway, and to identify areas of unmet need.Methods: In February 2024, bibliographic databases, a clinical trial registry, research funding portals, and company websites were searched for relevant records. Identified records were screened for relevance; they had to be a device or digital “innovative” technology for maintaining or recovering positive musculoskeletal health in adults. The characteristics of relevant technologies, delivery setting and outcomes assessed were coded. An EGM was generated to illustrate the results. Methods followed Cochrane Rapid Reviews Guidance to ensure robustness.Results: One hundred and nine relevant technologies were identified. Nearly half (49.5%) of these technologies were designed for use at home. Most (50.5%) were digital technologies (e.g., mobile apps) or devices with a digital component (19.3%) (e.g., digital pain reduction kit). The impact of these technologies was most assessed by changes seen in measures of pain and mobility.Discussion and Conclusion: The proportion of technologies used at home compared to other settings indicates a shift in the setting of therapy provision for individuals with MSK conditions. Future evaluative studies should consider measuring a broader set of outcome domains in order to understand the direct and wider impacts of health technologies for those with MSK conditions.

16 January 2026 in Research Square
Verified
Preprint
Open access
PDF file
SHShona Haston
Shona Haston
RKRyan Pw Kenny
Ryan Pw Kenny
NMNick Meader
Nick Meader
GSGemma Frances Spiers
Gemma Frances Spiers
LTLouise Tanner
Louise Tanner
GNGill Norman
Gill Norman
Rapid evidence synthesis plays a valuable role in healthcare. However, rapid reviews commonly do not undertake risk of bias assessment, even using truncated implementation approaches, despite its importance. In this work, we aimed to evaluate a rapid QUADAS-2 risk of bias method and compare the results with a standard QUADAS-2 assessment performed on 47 diagnostic test accuracy (DTA) studies for mild cognitive impairment (MCI). We also explored use of a rapid GRADE approach. The overall risk of bias agreed for the majority (29, 61.7%) of studies using the two methods, with major disagreements (high versus low) for two studies (4.3%), and minor disagreements (unclear vs high/low) for 16 studies (34.0%). For the 18 studies which had disagreements, using the QUADAS-2 rather than rapid assessment did not affect the GRADE certainty of evidence for five, five decreased by one grade, and two decreased by two grades. None increased due to the nature of the ‘one strike’ method adopted in the rapid approach. The collaborative nature of the rapid method may be beneficial in terms of robustness due to the inherent subjectiveness involved with any risk of bias assessment. In conclusion, this research demonstrated the suitability of using a rapid method to assess the risk of bias of DTAs. This method could be valuable for incorporating into rapid reviews to provide an evidence synthesis in a short timeframe without overly sacrificing robustness.

10 September 2026 in Pharmacogenomics
Verified
Journal Article
Open access
SHShona Haston
Shona Haston
JEJames Elgey
James Elgey
OEOlushola Ewedairo
Olushola Ewedairo
EGElizabeth Green
Elizabeth Green
AIAlex Inskip
Alex Inskip
AMAndrew Mkwashi
Andrew Mkwashi

25 March 2026 in JMIR Preprints
Verified
Preprint
Open access
SGSoheila Ghasri
Soheila Ghasri
EJEugenie Evelynne Johnson
Eugenie Evelynne Johnson
SHShona Haston
Shona Haston
KTKatie Twentyman
Katie Twentyman
OEOlushola Ewedairo
Olushola Ewedairo
MBMatthew Breckons
Matthew Breckons
BACKGROUND Unmet health and care needs in severe conditions are often intensified by delayed recognition and barriers to timely, appropriate care. Netnography, an adaptation of ethnography for online communities, offers a low-burden methods of examining how such needs are experienced and articulated in naturally occurring online interactions, including among populations facing stigma or complex care pathways. However, netnography is often inconsistently applied and ethical procedures are not always transparently reported. Furthermore, how this approach compares to other, more established methods is not well understood. OBJECTIVE To assess the feasibility of non-participatory netnography for identifying health and care needs of people in the United kingdom affected by advanced liver disease (ALD) and their caregivers, and to compare netnography-derived insights with a scoping review of recent UK-based literature. METHODS We conducted a non-participatory netnography of a UK-based ALD forum selected for relevance, sustained activity, and depth of discussion on care experiences. Posts and replies from May to September 2024 relating to health and care needs were analyzed using an iterative framework approach combining inductive and deductive coding. In parallel, we undertook a scoping review following JBIe guidance to identify UK-based studies published in English between January 2019 and October 2024 across major databases and selected grey literature sources. Findings from both methods were charted into a shared framework of needs domains to examine convergence and divergence. Ethical approval was obtained; administrator consent was secured; and privacy protections included removal of identifiers, minimal paraphrasing of quotations, and non-disclosure of the forum name. RESULTS For the netnography, 535 posts and 4,250 replies were identified, of which 155 posts/replies were relevant to ALD-related needs. Three primary domains were identified: medical, emotional and psychological, and financial. Forum users described unresolved symptoms; difficulties accessing timely appointments, procedures, and specialist support; diagnostic and prognostic uncertainty; limited dietary and self-management guidance; emotional distress; caregiver burden; alcohol-related stigma and relapse concerns; and financial strain related to employment disruption, benefits navigation, and, less commonly, seeking private care to bypass waiting times. The scoping review included 28 reports of 26 UK-based studies and corroborated many medical and emotional needs but reported comparatively fewer financial needs. It additionally highlighted behavioral/lifestyle regulation needs and selected social and cultural influences. CONCLUSIONS Non-participatory netnography appears feasible for identifying a broad range of ALD-related health and care needs and provided complementary patient and caregiver-framed insights that both aligned with and extended the recent UK evidence base. CLINICALTRIAL NA